Tacoma WA 溃疡性结肠炎临床试验
13项针对 溃疡性结肠炎的研究正在 Tacoma及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Site US-029, Tacoma
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
招募中2 期
- Digestive Health Specialists, Tacoma
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
招募中3 期
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Washington Gastroenterology - Tacoma, Tacoma
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Washington Gastroenterology - Tacoma, Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- GI Alliance Tacoma, Tacoma
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
招募中2 期
- Site 019, Tacoma
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
招募中观察性研究
- Washington Gastroenterology, Tacoma
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
招募中2/3 期
- MultiCare Health System, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
招募中3 期
- Multicare Health System Institute for Research and Innovation, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
招募中3 期
- MultiCare Institute for Research & Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
招募中2 期
- Mirador Therapeutics Selected Site, Tacoma
其他城市的 溃疡性结肠炎试验
- Orlando, FL21 项研究
- New York City, NY21 项研究
- Miami, FL20 项研究
- Houston, TX14 项研究
- San Diego, CA13 项研究
- Chicago, IL13 项研究
- St. Louis, MO13 项研究
- Tyler, TX13 项研究
- San Antonio, TX13 项研究
- Colorado Springs, CO12 项研究
- Boston, MA12 项研究
- Los Angeles, CA11 项研究
Tacoma的其他研究
- 非小细胞肺癌18 项研究
- 乳腺癌17 项研究
- 多发性骨髓瘤13 项研究
- 前列腺癌11 项研究
- 转移性癌症10 项研究
- 克罗恩病10 项研究
- 结直肠癌10 项研究
- 卵巢癌7 项研究
- 黑色素瘤7 项研究
- 癌症（所有类型）6 项研究
- 胃癌6 项研究
- 胰腺癌6 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。